May 31, 2026 08:00PM
May 31, 2026 08:00PM
May 21, 2026 07:49PM
May 21, 2026 07:49PM
May 21, 2026 07:49PM
May 10, 2026 08:00PM
Mar 1, 2026 07:00PM Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Jan 26, 2026 07:00PM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 18, 2025 12:00AM
Sep 7, 2025 08:30PM
Sep 7, 2025 08:30PM
Aug 27, 2025 06:08AM Innovent Announces 2025 Interim Results and Business Updates
Aug 24, 2025 08:00PM
Aug 24, 2025 08:00PM
Aug 4, 2025 08:00PM
Aug 4, 2025 08:00PM
Jul 23, 2025 10:36AM
Jul 16, 2025 08:00PM
Jul 16, 2025 08:00PM Nature Medicine Published Phase 1 Results of Innovent Biologics' Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Jul 16, 2025 08:00PM
Jun 30, 2025 12:04AM
Jun 15, 2025 08:00PM
Jun 4, 2025 08:23PM
Jun 3, 2025 08:00PM
Jun 2, 2025 09:00PM
Jun 1, 2025 08:00PM 2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorect
May 31, 2025 09:39PM
Mar 30, 2025 09:19PM
Mar 26, 2025 06:21AM
Mar 18, 2025 08:57PM
Mar 18, 2025 08:55PM
Mar 2, 2025 07:00PM
Feb 16, 2025 07:00PM Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer
Jan 15, 2025 07:00PM
Jan 2, 2025 07:00PM
Dec 20, 2024 07:10AM
Dec 15, 2024 06:57PM
Dec 15, 2024 06:55PM
Dec 8, 2024 07:00PM
Sep 3, 2024 08:00PM Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma
Aug 28, 2024 06:37AM
Jul 5, 2024 04:30AM
Jul 1, 2024 08:00PM
Jun 12, 2024 08:00PM
Jun 2, 2024 01:13AM
Jun 1, 2024 08:00PM
Mar 18, 2024 08:00PM Innovent Announces Primary Endpoint Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular Age-related Macular Degeneration (nAMD)
Mar 5, 2024 12:32AM

322,897 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All